Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 20 of about 20 for Novartis AG�
Company Exchange Symbol Last price Quote change Market cap
Valeant Pharmaceuticals Intl Inc NYSE VRX 257.53 +3.25 (1.28%) 88.01B
Valeant Pharmaceuticals International, Inc. is a specialty pharmaceutical and medical device company. The Company is engaged in developing, manufacturing, ...
Novartis AG (ADR) NYSE NVS 103.75 +0.57 (0.55%) 277.37B
Novartis AG provides healthcare solutions. The Company is a multinational group of companies specializing in the research, development, manufacturing and ...
Novartis AG VTX NOVN 101.00 +0.60 (0.60%) 270.38B
Novartis AG provides healthcare solutions. The Company is a multinational group of companies specializing in the research, development, manufacturing and ...
Valeant Pharmaceuticals Intl Inc TSE VRX 335.32 +4.46 (1.35%) 114.90B
Valeant Pharmaceuticals International, Inc. is a specialty pharmaceutical and medical device company. The Company is engaged in developing, manufacturing, ...
NOVARTIS AG BASL OTCMKTS NVSEF 104.20 +1.85 (1.81%) 273.99B
Celgene Corporation NASDAQ CELG 131.25 -0.63 (-0.48%) 103.76B
Celgene Corporation (Celgene), together with its subsidiaries, is an integrated biopharmaceutical company engaged primarily in the discovery, ...
VALEANT PHARMACEUT. INTL FRA BVF 234.93 +2.93 (1.26%)
NOVARTIS AG CEDEAR EACH REP 0.5 ADR BCBA NVS 0.0000
MorphoSys AG ETR MOR 73.47 -0.10 (-0.14%) 1.94B
... development for diabetic nephropathy and fibrotic diseases, well as five programs in the discovery phase and two pre-development programs with Novartis.
Valeant Pharma SWX VRX 197.60 0.00 (0.00%)
MorphoSys AG FRA MOR 73.76 +0.53 (0.72%) 1.96B
... development for diabetic nephropathy and fibrotic diseases, well as five programs in the discovery phase and two pre-development programs with Novartis.
Morphosys Ag (ADR) OTCMKTS MPSYY 40.15 0.00 (0.00%) 2.13B
... development for diabetic nephropathy and fibrotic diseases, well as five programs in the discovery phase and two pre-development programs with Novartis.
MORPHOSYS AG OTCMKTS MPSYF 82.08 0.00 (0.00%) 2.17B
MORPHOSYS AG O.N. NEUE ETR MORN 17.48
MORPHOSYS AG O.N. NEUE FRA MORN 17.00
MORPHOSYS AG O.N. NEUE ETR MORA 0.0000
MORPHOSYS AG O.N. NEUE FRA MORA 37.00
CELGENE CORP. DL-,01 FRA CG3 118.91 -0.68 (-0.57%)
Celgene Corp SWX CELG 129.60 0.00 (0.00%)
CELGENE CORP. DL-,01 ETR CG3 120.35 +0.30 (0.25%)